Pharmacy review for SA workers' compensation
Effective medication management for ReturnToWorkSA claimants with specialist pharmacy review
Published: 3 April 2026 | Updated: 3 April 2026
Overview of ReturnToWorkSA medication management
South Australia's workers' compensation scheme, administered by ReturnToWorkSA, operates under the Return to Work Act 2014. This legislation establishes a clear framework for medical management, rehabilitation, and return to work support. As an insurer managing claims within ReturnToWorkSA, your obligation to manage medications appropriately is both a regulatory requirement and a key driver of successful claim outcomes.
Medication management in South Australian workers' compensation is not simply about treating symptoms in isolation; it is about supporting the claimant's rehabilitation pathway. Unoptimised medications create barriers to functional recovery, complicate physiotherapy and psychological interventions, and extend claim duration. A specialist pharmacy review identifies these barriers and delivers practical recommendations aligned with your return to work objectives.
ReturnToWorkSA framework and medication oversight
Regulatory expectations
ReturnToWorkSA operates under principles of evidence-based, efficient medical management. While the scheme does not mandate pharmacy reviews, it expects insurers to exercise due diligence in managing treatment pathways. The return to work focus embedded in the legislation means your medication decisions should directly support functional recovery and capacity building, not prolong dependency on symptom suppression alone.
Core principle: Medical treatment in South Australian workers' compensation must be reasonable, necessary, and directly support the claimant's return to work journey. Medications that create barriers to rehabilitation (e.g., excessive sedation, cognitive impairment, or dependence risk) warrant careful review.
Insurer obligations under ReturnToWorkSA
As the insurer, you must manage the claim in accordance with the Return to Work Act 2014. This includes ensuring medical treatment is appropriate and evidence-based. When you refer for a pharmacy review, you are fulfilling this obligation by obtaining an independent, specialist assessment of medication appropriateness and alignment with rehabilitation goals.
Why pharmacy review is critical for South Australian claims
South Australian claims frequently develop complex medication regimens over time, particularly in chronic conditions. The risks of unmanaged polypharmacy are significant:
- Drug interactions increasing adverse events and hospitalisation risk
- Medication-induced functional impairment that complicates return to work efforts
- Long-term opioid or benzodiazepine use creating dependence that outlasts the injury
- Duplicate therapies where multiple practitioners prescribe similar agents independently
- Medications addressing side effects of other medications rather than the underlying injury
A pharmacy review provides:
- Comprehensive medication audit against current evidence and ReturnToWorkSA principles
- Risk stratification for interactions, adverse effects, and dependency potential
- Clear, prioritised recommendations for deprescribing or optimisation
- Implementation guidance that works within your South Australian prescriber network
- Enhanced alignment between medications and functional recovery goals
ReturnToWorkSA claim trajectory and optimal pharmacy review timing
The timing and nature of a pharmacy review should align with the claim's progression through the ReturnToWorkSA process:
| Claim phase | Typical medication profile | Pharmacy review rationale |
|---|---|---|
| Initial response (0-4 weeks) | Acute pain and inflammatory agents; short-term symptom control | Not typically required; early symptom management is appropriate |
| Early rehabilitation (4-12 weeks) | Transitioning from acute to maintenance; physio and psychology initiated | Consider if opioid escalation occurs or if medications impede rehabilitation participation |
| Active rehabilitation (3-6 months) | Stable medication base; polypharmacy likely; multiple comorbidities evident | Highly recommended; ensures medications support rather than impede recovery |
| Return to work phase (6+ months) | Medications optimised for work capacity; deprescribing underway | Valuable to ensure medications support work-related functional demands |
South Australia-specific medication management considerations
Prescriber landscape and collaboration
South Australia has a well-established network of general practitioners, specialists, and pain medicine practitioners. A pharmacy review integrated with this network ensures recommendations are practicable and prescriber collaboration is smooth. Effective reviews include consultation with the treating medical practitioner to understand their clinical reasoning and build agreement around proposed changes.
PBS and medication costs
Claimants in South Australia have standard access to PBS medications. ReturnToWorkSA does not provide separate medication funding pathways, so your medication costs are part of your overall medical management budget. A pharmacy review that optimises to evidence-based, cost-effective alternatives supports your financial management without compromising outcomes.
Return to work outcomes focus
ReturnToWorkSA emphasises return to work as the primary outcome measure. A pharmacy review that explicitly assesses the relationship between medications and work capacity (sedation, cognitive effects, physical capability) directly supports the scheme's core objective and strengthens your claim management story.
Conducting a pharmacy review referral in South Australia
Step 1: Identify the need
Trigger a review when: claim duration exceeds 12 weeks, polypharmacy (five or more medications) is evident, high-risk medications (opioids, benzodiazepines) are present, the claimant reports side effects affecting function, or rehabilitation progress has plateaued despite appropriate therapy inputs.
Step 2: Obtain claimant consent
Claimant buy-in is essential. Frame the review as an opportunity to optimise their medication regimen so they can participate more fully in rehabilitation and return to work. Explain that recommendations go to their treating doctor, and any changes are their doctor's decision in consultation with them.
Step 3: Provide comprehensive medication history
Supply the reviewer with injury details, complete medication list (with dosages and durations), relevant medical history, any past medication responses or reactions, and recent clinical notes from treating practitioners. Include information about functional goals and return to work timeframes.
Step 4: Collaborate with the treating doctor
Pharmacy review recommendations are most likely to be implemented when the treating doctor feels consulted and respected. Facilitate a three-way discussion between the reviewer, treating doctor, and claimant to discuss proposed changes and agree on implementation approach.
Step 5: Monitor and adjust
After implementation, monitor the claimant's response to medication changes. Assess whether deprescribing is successful, whether new agents are tolerated, and whether functional improvements are evident. Adjust further if needed.
Evidence-based medication principles for ReturnToWorkSA claims
Pain management approach
Current evidence-based pain management in rehabilitation prioritises non-pharmacological interventions (exercise, physiotherapy, psychological support) combined with targeted, evidence-supported medications. A structured approach to pain management in ReturnToWorkSA claims includes assessment of whether current opioid doses are evidence-supported or whether alternative approaches (neuropathic agents, topical therapies, psychological approaches) might be more effective for recovery.
Benzodiazepine use and management
Short-term benzodiazepines (2 to 4 weeks) may be appropriate for acute anxiety or muscle spasm associated with acute injury. Long-term use creates dependency, cognitive impairment, and is inconsistent with rehabilitation principles. A pharmacy review will assess whether benzodiazepines remain necessary and recommend time-limited use with cessation planning.
Deprescribing and medication rationalisation
As recovery progresses, medications introduced for acute symptoms often become unnecessary. A pharmacy review identifies deprescribing candidates and provides safe cessation protocols that minimise withdrawal effects and support the claimant's perception of recovery.
Common medication scenarios in South Australian workers' compensation
Chronic pain management
Claimants with chronic pain from musculoskeletal injury may be on long-acting opioids, multiple analgesics, and adjunctive agents. A pharmacy review assesses whether the opioid regimen is evidence-supported, whether dose escalation is medically justified, and whether deprescribing toward non-opioid or lower-opioid strategies is feasible and beneficial for functional recovery.
Mental health comorbidity
Injury-related anxiety or depression often develops, leading to concurrent antidepressant or anxiolytic therapy. A review ensures these agents are appropriately indicated, at evidence-based dosages, and not interacting with pain management medications in ways that impede recovery.
Polypharmacy for comorbid conditions
Claimants frequently have pre-injury comorbidities (hypertension, diabetes, chronic disease) alongside injury-related medications. A comprehensive review assesses the entire medication profile, looking for interactions, duplicate therapies, or medications that can be safely ceased or deprescribed as part of rehabilitation.
Measuring success in South Australian pharmacy reviews
Track these outcomes to demonstrate pharmacy review value in your ReturnToWorkSA claims:
- Medication rationalisation: Number of medications reduced or ceased per review
- High-risk medication deprescribing: Percentage of claimants safely withdrawn from opioids or benzodiazepines
- Return to work progress: Time to work resumption before and after review; increased work hours or capacity post-review
- Functional improvement: Physiotherapy participation and progress; self-reported functional recovery
- Claim cost management: Medication expenditure before and after; reduced complication-related costs
Key contacts and resources for South Australian workers' compensation
When managing ReturnToWorkSA claims, these resources support medication management decisions:
- ReturnToWorkSA: https://www.rtwsa.gov.au - The regulatory authority; relevant fact sheets on medical management
- Therapeutic Guidelines: Current evidence-based prescribing recommendations used by Australian healthcare professionals
- PBS (Pharmaceutical Benefits Scheme): Reference for medication eligibility and restrictions
- SA Health: Local health service information and clinical guidance
Optimise medications for South Australian workers' compensation claimants
IMM delivers expert pharmacy reviews tailored to ReturnToWorkSA claims. Our pharmacists work collaboratively with your medical teams and claimants to ensure medications support rehabilitation and return to work objectives.
Request a Medication Review
